glp-1 risk factors GLP-1-based medications: Mechanisms involved in obesity treatment Exploring the Science and Practice

glp-1 risk factors

glp-1 risk factors GLP-1-based medications: Mechanisms involved in obesity treatment Exploring the Science and Practice

Name: glp-1 risk factors GLP-1-based medications: Mechanisms involved in obesity treatment Exploring the Science and Practice
Brand: haus-pacher.at
SKU: 98429381724
Price: 25.52 USD
Availability: InStock
Rating: 4.710100000000001 (14 reviews)

SKU: 98429381724

4.7

USD25.52 USD66.52

Pay in 4 interest-free payments of $6.38 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 15 - Aug 20

Description

Inhibition of intestinal nutrient absorption, as with orlistat

J., Flowers, D

Patients on multiple peptides

2016 May 1:304:67-70

The widespread use of these drugs for weight loss has sparked debates as to the medicalisation of obesity and the ethics of using pharmaceuticals for body modification (Arillotta et al., 2023)

Without regular meals or familiar eating patterns to fall back on, hunger after GLP-1 may show up more suddenly and feel more intense, especially after long stretches without food